Anti-OBP2A/ LCN13/ OBP functional antibody

Anti-OBP2A/ LCN13/ OBP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OBP2A/OBP2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1145-Ab-1/ GM-Tg-hg-SE1145-Ab-2Anti-Human OBP2A monoclonal antibodyHuman
GM-Tg-rg-SE1145-Ab-1/ GM-Tg-rg-SE1145-Ab-2Anti-Rat OBP2A monoclonal antibodyRat
GM-Tg-mg-SE1145-Ab-1/ GM-Tg-mg-SE1145-Ab-2Anti-Mouse OBP2A monoclonal antibodyMouse
GM-Tg-cynog-SE1145-Ab-1/ GM-Tg-cynog-SE1145-Ab-2Anti-Cynomolgus/ Rhesus macaque OBP2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1145-Ab-1/ GM-Tg-felg-SE1145-Ab-2Anti-Feline OBP2A monoclonal antibodyFeline
GM-Tg-cang-SE1145-Ab-1/ GM-Tg-cang-SE1145-Ab-2Anti-Canine OBP2A monoclonal antibodyCanine
GM-Tg-bovg-SE1145-Ab-1/ GM-Tg-bovg-SE1145-Ab-2Anti-Bovine OBP2A monoclonal antibodyBovine
GM-Tg-equg-SE1145-Ab-1/ GM-Tg-equg-SE1145-Ab-2Anti-Equine OBP2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1145-Ab-1/ GM-Tg-hg-SE1145-Ab-2; GM-Tg-rg-SE1145-Ab-1/ GM-Tg-rg-SE1145-Ab-2;
GM-Tg-mg-SE1145-Ab-1/ GM-Tg-mg-SE1145-Ab-2; GM-Tg-cynog-SE1145-Ab-1/ GM-Tg-cynog-SE1145-Ab-2;
GM-Tg-felg-SE1145-Ab-1/ GM-Tg-felg-SE1145-Ab-2; GM-Tg-cang-SE1145-Ab-1/ GM-Tg-cang-SE1145-Ab-2;
GM-Tg-bovg-SE1145-Ab-1/ GM-Tg-bovg-SE1145-Ab-2; GM-Tg-equg-SE1145-Ab-1/ GM-Tg-equg-SE1145-Ab-2
Products NameAnti-OBP2A monoclonal antibody
Formatmab
Target NameOBP2A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OBP2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1145-Ag-1Recombinant multi-species OBP2A/ LCN13/ OBP protein


    Target information

    Target IDGM-SE1145
    Target NameOBP2A
    Gene ID29991
    Gene Symbol and SynonymshOBPIIa,LCN13,OBP,OBP2A,OBP2C,OBPIIa
    Uniprot AccessionQ9NY56
    Uniprot Entry NameOBP2A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000122136
    Target ClassificationN/A

    The target: OBP2A, gene name: OBP2A, also named as LCN13, OBP, OBP2C, OBPIIa, hOBPIIa. This gene encodes a small extracellular protein belonging to the lipocalin superfamily. The protein is thought to transport small, hydrophobic, volatile molecules or odorants through the nasal mucus to olfactory receptors, and may also function as a scavenger of highly concentrated or toxic odors. The protein is expressed as a monomer in the nasal mucus, and can bind diverse types of odorants with a higher affinity for aldehydes and fatty acids. This gene and a highly similar family member are located in a cluster of lipocalin genes on chromosome 9. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.